| | 
Part, Chapter, Paragraph
1 II, 5. 1. 1| human papilloma virus or HPV (Stewart and Kleihues, 2003).
2 II, 5. 1. 1| Kleihues, 2003). Genital HPV is usually spread by sexual
3 II, 5. 1. 1| Abnormal cells, derived from HPV infection, take many years
4 II, 5. 3.Acr| GDP~Gross Domestic Product~HPV~Human Papilloma Virus~HTA~
5 II, 5. 3. 4| human papilloma virus or HPV (Stewart and Kleihues, 2003).
6 II, 5. 3. 4| Kleihues, 2003). Genital HPV is usually spread by sexual
7 II, 5. 3. 4| Abnormal cells, derived from HPV infection, take many years
8 II, 5. 3. 5| is mainly related to the HPV (Human Papilloma Virus)
9 II, 5. 3. 5| cervical lesions caused by HPV infection before becoming
10 II, 5. 3. 5| two countries have similar HPV infection exposure and the
11 II, 5. 3. 5| could be caused by different HPV exposure and by the different
12 II, 6.Acr | Haemophilus Influenzae type B~HPV~Human Papilloma Virus~IDU~
13 II, 6. 3. 3| with human papilloma virus (HPV) has received renewed interest
14 II, 6. 3. 3| to define the profile of HPV strains most prevalent in
15 II, 6. 3. 5| human papilloma virus (HPV), and rotavirus). This raises
16 II, 9 | and human papilloma virus (HPV). Risk factors for STIs
17 II, 9. 2. 4| and human papilloma virus (HPV). Risk factors for STIs
18 II, 9. 3. 1| the human papilloma virus (HPV) are often hidden and can
19 II, 9. 3. 1| occur years after infection. HPV produces genital warts which
20 II, 9. 3. 1| cancer shows evidence of HPV infection (Madeleine et
21 II, 9. 3. 1| genital warts. A vaccine for HPV has become recently available
22 II, 9. 3. 1| immunodeficiency virus infections~HPV~Human papilloma virus~IDF
23 IV, 11.Acr | and Healthcare Federation~HPV~Human Papilloma Virus~NICE~
24 IV, 11. 4 | against Human Papilloma Virus (HPV) to reduce the risk of cervical
25 IV, 12. 2 | Papilloma Virus infection (HPV), which is a risk factor
26 IV, 12. 10 | diseases (i.e. Hepatitis B & C, HPV, Syphilis, and Gonorrhea).
|
|
| |
